Status:
COMPLETED
Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Hypoglycemia
Eligibility:
All Genders
Up to 48 years
Phase:
PHASE2
Brief Summary
Thesis Infants of diabetic mothers are at high risk to develop hypoglycemia after birth. After birth, glucose and ketone bodies are the main substrates of brain energy. Under normal condition, the ad...
Eligibility Criteria
Inclusion
- asymptomatic hypoglycemia
- infant of insulin treated diabetic mother
- AGA or LGA
- no other known medical problems
Exclusion
- concurrent medical problems
- symptomatic hypoglycemia
- glucose under 20 mg%
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
End Date :
May 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00434772
Start Date
December 1 2007
End Date
May 1 2009
Last Update
May 28 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Share Zedek Medical Center
Jerusalem, Israel, 91031